To experimentally verify our prediction, we have constitutively overexpressed Rora in human osteosarcoma cells harbouring a circadian reporter (Bmal1-promoter-luc) [42], [89] which resulted in loss of oscillations, in agreement with our modelling data (Figure 7B). The gene discussed is RORA; the disease is osteosarcoma.